Prohibition of Insider Trading

DR. LAL PATHLABS LIMITED

General information about company

Scrip Code		539524
NSE Symbol		LALPATHLAB
MSEI Symbol		NOTLISTED
Name of the Signatory		VINAY GUJRAL
Designation of Signatory		Company Secretary and Compliance Officer
Place		GURUGRAM
Date of Filing		06-08-2026
ISIN Code		INE600L01024
Disclosure under Regulation		Regulation 7 (2)
Revised Filing		No

PIT Disclosure

Sr. No.	Type of instrument	Description of type of instrument (applicable in case of other is selected)	Category of person	Name of the person	CIN / DIN	Securities held prior to acquisition / disposal		Securities acquired / disposed			Securities held post acquisition / disposal		Date of allotment advice / acquisition of shares / sale of shares specify		Mode of acquisition / disposal	Date of intimation to company	Type of contract	Contract specification	Buy		Sell		Exchange on which the trade was executed	Notes
						No. of security	% of shareholding	No. of security	Value of security (in Rs.)	Transaction type	No. of security	% of shareholding	From date	To date					Notional value	No. of units (contracts × lot size)	Notional value	No. of units (contracts × lot size)
						No. of security	% of shareholding	No. of security	Value of security (in Rs.)	Transaction type	No. of security	% of shareholding	From date	To date					Notional value	No. of units (contracts × lot size)	Notional value	No. of units (contracts × lot size)
1	Equity		Promoter and Director	(Hony) Brig Dr Arvind Lal	00576638	50530886	30.14%	320000	609,742,252.00	Sell	50210886	29.95%	03-08-2026	04-08-2026	Market Sale	05-08-2026							NSE
2	Equity		Other	Dr. Lal PathLabs Employee Welfare Trust		594798	0.35%	211050	256,104,786.00	Buy	805848	0.48%	06-08-2026	06-08-2026	ESOP	06-08-2026							NA	Textual Information(1)

Text Block

Textual Information(1)

It may be kindly noted that shares were Acquired at Effective Exercise price (Post Bonus Issue- 2025) of INR 1087.47/-, 965.025/-, 1425.715/- & 1452.195/- per share (as the case may be) under Company’s ESOP plan(s).